කේම්බ්රිජ් විශ්වවිද්යාලයේ තන්තුකවාහිනී වසංගත අධ්යයන ඒකකයේ නිලධාරීන් පිරිසක් 2018 ජුලි මස 26 වැනිදා ශ්රී ජයවර්ධනපුර විශ්වවිද්යාලයේ ක්ෂේත්ර සංචාරයක නිරත විය. ශ්රී ලංකාවේ බෝනොවන වසංගත රෝග අධ්යයන වැඩිදියුණු කිරීම මඟින් සෞඛ්ය පද්ධති ශක්තිමත් කිරීම ප්රධාන අරමුණ කරගත් මෙම වැඩසටහන පිලිබඳ වැඩිදුර විස්තර සඳහා පිවිසෙන්න :
The Cardiovascular Epidemiology Unit University of Cambridge is to begin their study: Strengthening Health systems by Improving Noncommunicable disease Epidemiology in 91ý (SHINES) in September 2018. Key officials of this project visited the 91ý on the 26th of July 2018 to review how the of the , USJP is setting up the location to start the SHINES project.
The key officials of the project includes , Dr. Kumudu Wijewardene, Dr. Emanuele Di Angelantonio, Prof. John Danesh (joint Principal Investigators), Dr. Sarath Amunugama, Dr. Virginie Mallawarachchi, Dr. T. Kumanan, Dr. Subramniam Shivaganesh, Nimal Gamagedara (co-investigators, clinical, public health and epidemiological sciences), Dr. Karen Heasley (project coordinator), Ms. Catherine Perry, Mr Steve Ellis (statistical sciences and data management), Dr. Richard Houghton, Ms. Beth Collins, Ms. Binder Kaur (administration)
The SHINES project will be looking into Non-communicable Diseases (NCDs) that are the leading causes of death and disability in 91ý and elsewhere in South Asia. The project has been designed as a prospective study with the resource of 10,000 community-based people from 91ý.
“SHINES study includes several inter-related components to study potential environmental, biochemical and hereditary risk factors of cardiometabolic and other NCDs in 91ý and serves as a population platform for next-generation NCD prevention trials” the officials said.
The key objectives of the SHINES prospective cohort study are to:
(1) Assess reliably the burden of environmental and metabolic risk factors in 91ý, by population subgroups (eg rural vs urban; by ethnicity) “bܰ”]
(2) Quantify any synergistic impact of these risk factors on incident NCDs “aپDZDz”]
(3) Help monitor discrepant risk factor patterns unique to this population (high metabolic dysfunction; coconut oil consumption) [“monitoring trends”]
(4) compare risk profiles between various population (eg, across other South Asians regionally; local vs. immigrant 91ýns through joint analyses with the existing cohorts) [“health transition”]
(5) Serve as a bio resource to determine the complex interplay between genes and environmental factors among South Asians and between different genes on disease risk “iԳٱ”]
(6) Contribute in developing a “South Asian” risk score to predict future CVD risk and to compare with the established risk stratification approaches [“risk prediction”]
(7) Use this population platform to design and assess simple, scalable and cost-effective interventions that can improve NCD prevention in 91ý (eg, those to reduce metabolic dysfunction in this population) [“trial platform”]Ի
(8) Help enhance the general scientific and public health infrastructure and capacities in 91ý [“capacity building”].
Senior Professor Sampath Amaratunge, Vice Chancellor of the University stated that the University will provide its utmost support for the research study conducted through this project.
Related links: